チオペプチド抗生物質に対する微生物耐性の分子決定因子
Sascha Baumann1, Sebastian Schoof, Marcel Bolten
1Fakultat Chemie, Technische Universität Dortmund, Otto-Hahn-Strasse 6, D-44221 Dortmund, Germany.
Journal of the American Chemical Society
|May 6, 2010
まとめ
チオペプチド抗生物質は,細菌のリボソームを標的とする. リボソームRNA (rRNA) の突然変異は結合に影響し,リボソームタンパク質L11の突然変異は,タンパク質合成の阻害をバイパスすることで,バイサイクルチオペプチドに対する耐性を授与する.
科学分野:
- 微生物学 微生物学とは
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- リボソームで生成されるチオペプチド抗生物質は強力な抗菌剤です.
- これらの化合物は,細菌のリボソームのGTPase関連領域 (GAR) を標的とし,タンパク質合成を阻害します.
- 耐性メカニズムを理解することは,新しい抗生物質の開発に不可欠です.
研究 の 目的:
- 特定のリボソーム変異がチオペプチド抗生物質の結合と耐性に対する影響を調査する.
- チオペプチドとリボソームの相互作用における23S rRNAとリボソームタンパク質L11の役割を解明する.
- バクテリアのモデルシステムにおける耐性を与える突然変異を検証する.
主な方法:
- GTPase関連領域 (GAR) 変異体のインビトロ再構成.
- 光プローブを用いた定量結合研究.
- サイト・ディレクテッド・ミュータゲネシスと,バチルス・サブティリスの溶解.
主要な成果:
- 23S rRNAの結合部位における単位変異は,A1067が決定的であり,チオペプチドの親和性を直接変化させた.
- リボソームタンパク質L11のP25残留は,モノサイクロンチオペプチド結合に不可欠であり,自己抵抗性を与えました.
- バイサイクルチオペプチドは,L11変異を持つリボソームに対する高い親和性を維持し,タンパク質合成のブロックを回避することによって,バシルス・サブティリスに抵抗性を授与しました.
結論:
- リボソームタンパク質L11の変異は,リボソームが抗生物質誘発のタンパク質合成停止を回避できるようにすることで,バイサイクルチオペプチドに対する耐性を授与する.
- rRNAの改変と異なり,L11変異はバイサイクルチオペプチド結合を防ぐのではなく,結合の下流の結果を変化させます.
- これらの発見は,チオペプチド耐性メカニズムと抗生物質開発のための潜在的な戦略の洞察を提供します.
関連する概念動画
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...


